Chemopreventive agents: Protease inhibitors

Pharmacology and Therapeutics

Volumn 78, Issue 3, 1998, Pages 167-209

  Kennedy, Ann R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bowman Birk inhibitorz; Carcinogenesis; Inflammation; Protease inhibitor

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; BOWMAN BIRK INHIBITOR; PROTEINASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER; CANCER PREVENTION; CARCINOGENESIS; DOSE RESPONSE; DRUG METABOLISM; EXENCEPHALY; HAIR LOSS; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOGENICITY TESTS; HUMANS; INFLAMMATION; PROTEASE INHIBITORS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

EID: 0031782418     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00010-2     Document Type: Review

References (353)

1. Adler G., Mullenhoff A., Bozkurt T., Koop I., Goke B., Beglinger C., Arnold R. Pancreatic function and plasma CCK in humans after ingestion of a proteinase inhibitor (Foy-305). Dig. Dis. Sci. 31:1986;1123.
2. Adler, G., Mullenhoff, A. Bozkurt, T., Goke, B., Koop, I. and Arnold, R. (1988) Comparison of the effect of single and repeated administrations of a protease inhibitor (camostate) on pancreatic secretion in man. Scand. J. Gastoenterol. 23: 158-162.
3. Adrian T.E., Pasquali C., Pescosta F., Bacarese-Hamilton A.J., Bloom S.R. Soy-induced pancreatic hypertrophy and rise of circulating cholecystokinin. Gut. 23:1982;A889.
4. Andrén-Sandberg A., Ihse I. Regulatory effects on the pancreas of intraduodenal pancreatic juice and trypsin in the Syrian golden hamster. Scand. J. Gastroenterol. 18:1983;697-706.
5. Angel P., Imagawa M., Chiu R., Stein B., Imbra R.J., Rahmsdorf H.J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible gene contains a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 49:1987;729-739.
6. Armstrong B., Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary factors. Int. J. Cancer. 15:1975;617-631.
7. Ashendel C.L. The phorbol ester receptor. a phospholipid-regulated protein kinase Biochim. Biophys. Acta. 822:1985;219-242.
8. Ausman L.M., Harwood J.P., King N.W., Sehgal P.K., Nicolosi R.J., Hegsted M.D., Liener I.E., Donatucci D., Tarcza J. The effects of long-term soy protein and milk protein feeding on the pancreas of Cebus albifrons monkeys. J. Nutr. 115:1985;1691-1701.
9. Baturay N.Z., Kennedy A.R. Pyrene acts as a cocarcinogen with the carcinogens, benzo(a)pyrene, β-propiolactone and radiation in the induction of malignant transformation of cultured mouse fibroblasts; soybean extract containing the Bowman-Birk inhibitor acts as an anticarcinogen. Cell Biol. Toxicol. 2:1986;21-32.
10. Beatty K., Bieth J., Travis J. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J. Biol. Chem. 255:1980;3931-3934.
11. Becker F.F. Inhibition of spontaneous hepatocarcinogenesis in C3H/Hen mice by Edi Pro A, an isolated soy protein. Carcinogenesis. 2:1981;1213-1214.
12. 2-Mg) from human blood serum. Radiat. Res. 60:1974;501-505.
13. Beutler B., Cerami A. The common mediator of shock, cachexia and tumor necrosis. Adv. Immunol. 42:1988;213-231.
14. Beutler B., Milsark I.W., Cerami A. Cachectin/tumor necrosis factor. production, distribution and metabolic fate in vivo J. Immunol. 135:1985;3972-3977.
15. Billings, P. C. (1993) Approaches to studying the target enzymes of anticarcinogenic protease inhibitors. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 191-198, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
16. Billings P.C., Habres J.M. A growth regulated protease activity which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc. Natl. Acad. Sci. USA. 89:1992;3120-3124.
17. Billings P.C., Carew J.A., Keller-McGandy C.E., Goldberg A., Kennedy A.R. A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors. Proc. Natl. Acad. Sci. USA. 84:1987;4801-4805.
18. Billings P.C., St. Clair W., Owen A.J., Kennedy A.R. Potential intracellular target proteins of the anticarcinogenic Bowman-Birk protease inhibitor identified by affinity chromatography. Cancer Res. 48:1988;1798-1802.
19. Billings P.C., Morrow A.R., Ryan C.A., Kennedy A.R. Inhibition of radiation-induced transformation of C3H/10T1/2 cells by carboxypeptidase Inhibitor I and Inhibitor II from potatoes. Carcinogenesis. 10:1989;687-691.
20. Billings P.C., Habres J.M., Kennedy A.R. Inhibition of radiation-induced transformation of C3H10T1/2 cells by specific protease substrates. Carcinogenesis. 11:1990;329-332. a.
21. Billings P.C., Longnecker M.P., Keary M., Taylor P.R. Protease inhibitor content of human dietary samples. Nutr. Cancer. 14:1990;81-93. b.
22. Billings P.C., Newberne P., Kennedy A.R. Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine. Carcinogenesis. 11:1990;1083-1086. c.
23. Billings P.C., Brandon D.L., Habres J.M. Internalization of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Eur. J. Cancer. 27:1991;903-908. a.
24. Billings P.C., Habres J.M., Liao D.C., Tuttle S.W. A protease activity in human fibroblasts which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Cancer Res. 51:1991;5539-5543. b.
25. Billings P.C., St. Clair W., Maki P.A., Kennedy A.R. Distribution of the Bowman Birk protease inhibitor in mice following oral administration. Cancer Lett. 62:1992;191-197.
26. Billings P.C., Maki P.A., Kennedy A.R. Effect of modifiers of arachidonic acid metabolism on radiation transformation and eicosanoid formation in C3H10T1/2 cells. Cancer Biophys. Biochem. 14:1994;211-220.
27. Birk Y. Purification and some properties of a highly active inhibitor of trypsin and chymotrypsin from soybeans. Biochim. Biophys. Acta. 54:1961;378-381.
28. Birk, Y. (1974) Structure-activity relationship of several trypsin and chymotrypsin inhibitors from legume seeds. In: Proteinase Inhibitors, pp. 355-361, Fritz, H., Tschesche, H., Green, L. J. and Truscheit, E. (eds.) Springer-Verlag, Heidelberg.
29. Birk, Y. (1976) Proteinase inhibitors from plant sources. In: Methods in Enzymology, Vol. 45, Proteolytic Enzymes, Part B, pp. 695-739, Lorand, L. (ed.) Academic Press, New York.
30. Birk Y. The Bowman-Birk Inhibitor. Int. J. Pept. Protein Res. 25:1985;113-131.
31. Birk, Y. (1993) Protease inhibitors of plant origin and role of protease inhibitors in human nutrition: overview. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 97-106, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
32. Blondell J.M. Urban-rural factors affecting cancer mortality in Kentucky, 1950-1969. Cancer Detect. Prev. 11:1988;209-223.
33. Bodwell, C. E. and Hopkins, D. T. (1985) Nutritional characteristics of oilseed proteins. In: New Protein Foods, Vol. 5, Seed Storage Proteins, Ch. VII, pp. 221-257, Altschul, A. A. and Wilcke H. L. (eds.) Academic Press, Orlando.
34. Bohe M. Pancreatic and granulocytic endoproteases in faecal extracts of patients with active ulcerative colitis. Scand. J. Gastroenterol. 22:1987;59-64.
35. Bohe M., Genell S., Ohlsson K. Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease. Scand. J. Gastroenterol. 21:1986;598-604.
36. Boone C.W., Kelloff G.J. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents. relationships to fundamental properties of preinvasive (intraepithelial) neoplasia J. Cell. Biochem. 19(Suppl.):1994;10-22.
37. Boorman G.A., Eustis S.L. Proliferative lesions of the exocrine pancreas in male F344/N rats. Environ. Health Perspect. 56:1984;213-214.
38. Boorman G.A., Banas D.A., Eustis S.L., Haseman J.K. Proliferative exocrine pancreatic lesions in rats. The effect of sample size on the incidence of lesions. Toxicol. Pathol. 15:1987;451-456.
39. Borek C., Cleaver J.E. Protease inhibitors neither damage DNA nor interfere with DNA repair or replication in human cells. Mutat. Res. 82:1981;373-380.
40. Borek C., Miller R.C., Pain C., Troll W. Conditions for inhibiting and enhancing effects of the protease inhibitor antipain on x-ray-induced neoplastic transformation in hamster and mouse cells. Proc. Natl. Acad. Sci. USA. 76:1979;1800-1803. Erratum: Proc. Natl. Acad. Sci. USA 76: 6699 (1979).
41. Bowman D.E. Differentiation of soybean antitryptic factors. Proc. Soc. Exp. Biol. Med. 63:1946;547-550.
42. Bowman, D. E. (1993) Discovery and background of the Bowman-Birk protease inhibitors. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 93-96, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
43. Bozzini, A. and Silano, V. (1978) Control through breeding methods of factors affecting nutritional quality of cereals and grain legumes. In: Nutritional Improvement of Food and Feed Proteins, pp. 249-274, Friedman, M. (ed.) Plenum Press, New York.
44. Brandon D.L., Bates A.H., Friedman M. Monoclonal antibody-based enzyme immunoassay of the Bowman-Birk protease inhibitor of soybeans. Agric. Food Chem. 37:1989;1192-1196.
45. Brent R.L. Vulnerability of the preimplantation mammalian embryo. Pediatr. Res. 12:1978;392.
46. Brown W., Ryan C.A. Isolation and characterization of a wound-induced trypsin inhibitor from alfalfa leaves. Biochemistry. 23:1984;3418-3422.
47. Buell P. Changing incidence of breast cancer in Japanese-American women. J. Natl. Cancer Inst. 51:1973;1479-1483.
48. Caggana M., Kennedy A.R. C-fos mRNA levels are reduced in the presence of antipain and the Bowman-Birk inhibitor. Carcinogenesis. 10:1989;2145-2148.
49. Calaf G., Russo J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis. 14:1993;483-492.
50. Carew J.A., Kennedy A.R. Identification of a proteolytic activity which responds to anticarcinogenic protease inhibitors in C3H10T1/2 cells. Cancer Lett. 49:1990;153-163.
51. Carroll K.K., Khor H.T. Dietary fat in relation to tumorigenesis. Prog. Biochem. Pharmacol. 10:1975;307-353.
52. Chang J.D., Kennedy A.R. Cell cycle progression of C3H10T1/2 and 3T3 cells in the absence of a transient increase in c-myc RNA levels. Carcinogenesis. 9:1988;17-20.
53. Chang, J. D. and Kennedy, A. R. (1993) Suppression of c-myc by anticarcinogenic protease inhibitors. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 265-280, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
54. Chang J.D., Billings P., Kennedy A.R. C-myc expression is reduced in antipain-treated proliferating C3H10T1/2 cells. Biochem. Biophys. Res. Commun. 133:1985;830-835.
55. Chang J.D., Li J.-H., Billings P.C., Kennedy A.R. Effects of protease inhibitors on c-myc expression in normal and transformed C3H10T1/2 cells. Mol. Carcinog. 3:1990;226-232.
56. Chapman H.A. Jr., Stone O.L. Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors J. Clin. Invest. 74:1984;1693-1700.
57. Chernick S.S., Lepkovsky S., Chaikoff I.L. A dietary factor regulating the enzyme content of the pancreas. changes induced in size and proteolytic activity of the chick pancreas by the ingestion of raw soybean meal Am. J. Physiol. 155:1948;33-41.
58. Churella H.R., Yao B.C., Thompson W.A.B. Soybean trypsin inhibitor activity of soy infant formulas and its nutritional significance for the rat. J. Agric. Food Chem. 24:1976;393-397.
59. Clark D.A., Day R., Seidah N., Moody T.W., Cuttitta F., Davis T.P. Protease inhibitors suppress in vitro growth of human small cell lung cancer. Peptides. 14:1993;1021-1028.
60. Clifton K.H., Domann F.E., Groch K.M. On the cells of origin of radiogenic thyroid cancer. new studies based on an old idea J. Radiat. Res. 2(Suppl.):1991;143-155.
61. Coburn M., Schuel H., Troll W. A hydrogen peroxide block to polyspermy in the sea urchin, Arbacia punctulata. Dev. Biol. 84:1981;235-238.
62. Corasanti J.G., Hobika G.H., Markus G. Interference with dimethylhydrazine induction of colon tumors in mice by ε-aminocaproic acid. Science. 216:1982;1020-1021.
63. Correa P. Epidemiologic correlations between diet and cancer frequency. Cancer Res. 41:1981;3685-3690.
64. Corwin L.M., Gordon R.K. Vitamin E and immune regulation. Ann. NY Acad. Sci. 393:1982;437-451.
65. Crass R.A., Morgan R.G.H. The effect of long-term feeding of soya bean flour diets on pancreatic growth in the rat. Br. J. Nutr. 47:1982;119-129.
66. Das, K. M. (1991) Some current perspectives on the etiology and pathogenesis of ulcerative colitis. In: Ulcerative Colitis, pp. 47-54, O'Morain, C. A. (ed.) CRC Press, Boca Raton.
67. Dayal, Y. and DeLellis, R. A. (1989) The gastrointestinal tract. In: Robbins Pathologic Basis of Disease, 4th edn., pp. 827-910, Cotran, R. S., Kumar, V. and Robbins, S. L. (eds.) W. B. Saunders Co., Philadelphia.
68. Diaz G.R., Devaux M.A., Johnson C.D., Adrich Z., Sarles H. Physiological conditions for the study of basal and meal-stimulated exocrine pancreatic secretion in the dog. Absence of feedback inhibition of basal secretion. Can. J. Physiol. Pharmacol. 60:1982;1287-1295.
69. DiPaolo J.A., Amsbaugh S.C., Popescu N.C. Antipain inhibits N-methyl-N′-nitro-N-nitrosoguanidine-induced transformation and increases chromosomal aberrations. Proc. Natl. Acad. Sci. USA. 77:1980;6649-6653.
70. Dittmann K., Loffler H., Bamberg M., Rodemann H.P. Bowman-Birk proteinase inhibitor (Bbi) modulates radiosensitivity and radiation-induced differentiation of human fibroblasts in culture. Radiother. Oncol. 34:1995;137-143.
71. Doell B.H., Ebden C.J., Smith C.A. Trypsin inhibitor activity of conventional foods which are part of the British diet and some soya products. Qual. Plant. Plant Foods Hum. Nutr. 31:1981;139-150.
72. Doll R., Peto R. The causes of cancer. quantitative estimates of avoidable risks of cancer in the United States today J. Natl. Cancer Inst. 66:1981;1193-1308.
73. Douglas B.R., Woutersen R.A., Jansen J.B.M.J., de Jong A.J.L., Rovati L.C., Lamers C.B.H.W. Modulation by CR-1409 (Lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Cancer Res. 49:1989;2438-2441.
74. Dunn J.E. Cancer epidemiology in populations of the United States with emphasis on Hawaii and California and Japan. Cancer Res. 35:1975;3240-3245.
75. Durbec J.P., Chevilotte G., Bidart J.M., Berthezene P., Sarels H. Diet, alcohol, tobacco and risk of cancer of the pancreas - a case control study. Br. J. Cancer. 47:1983;463-470.
76. Eisen V., Wilson C. The effect of β-irradiation on skin histamine and vascular responses in the rat. J. Physiol. 136:1957;122-139.
77. Ekrami H., Kennedy A.R., Witschi H., Shen W.C. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent. J. Drug Target. 1:1993;41-49.
78. Ekrami H., Kennedy A.R., Shen W.C. Disposition of positively-charged Bowman-Birk protease inhibitor conjugates in mice. influence of protein conjugate charge-density and size on lung targeting J. Pharm. Sci. 84:1995;456-461. a.
79. Ekrami H.M., Kennedy A.R., Shen W.C. Water-soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptides. FEBS Lett. 371:1995;283-286. b.
80. Ethier S.P., Ullrich R.L. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice. Cancer Res. 42:1982;1753-1760.
81. Evans S.M., Szuhaj B.F., Van Winkle T., Michel K., Kennedy A.R. Protection against metastasis of radiation induced thymic lymphosarcoma and weight loss in C57B1/6NCr1BR mice by an autoclave resistant factor present in soybeans. Radiat. Res. 132:1992;259-262.
82. Fabre F., Roman H. Genetic evidence for inducibility of recombination competence in yeast. Proc. Natl. Acad. Sci. USA. 74:1977;1667-1671.
83. Fahmy M.J., Fahmy O.G. Intervening DNA insertions and the alteration of gene expression by carcinogens. Cancer Res. 40:1980;3374-3382.
84. Flavin D.F. The effect of soybean trypsin inhibitors on the pancreas of animals and man. Vet. Hum. Toxicol. 24:1982;25-28.
85. Flick M.B., Kennedy A.R. Effect of protease inhibitors on DNA amplification in SV40-transformed Chinese hamster embryo cells. Cancer Lett. 56:1991;102-108.
86. Folsch U.R., Winckler K., Wormsley K.G. Effect of a soybean diet on enzyme content and ultrastructure of the rat exocrine pancreas. Digestion. 11:1974;161-171.
87. Fontham, E. and Correa, P. (1993) The epidemiologic approach to the study of protease inhibitors. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 1-8, Troll, W. and Kennedy, A. (eds.) Plenum Publishing Corporation, New York and London.
88. Ford, J. E. (1981) Microbiological methods for protein quality assessment. In: Protein Quality in Humans: Assessment and In Vitro Estimation, pp. 278-301, Bodwell, C. E., Adkins, J. S. and Hopkins, D. T. (eds.) AVI Publishing Company, Inc., Westport.
89. Frenkel K. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther. 53:1992;127-166.
90. 2 formation by activated human polymorphonuclear leukocytes. Carcinogenesis. 8:1987;1207-1212.
91. Fushiki T., Iwai K. Two hypotheses on the feedback regulation of pancreatic enzyme secretion. FASEB J. 3:1989;121-126.
92. Gallaher D., Schneeman B.O. Nutritional and metabolic response to plant inhibitors of digestive enzymes. Adv. Exp. Med. Biol. 199:1986;167-184.
93. Garte S.J., Currie D.C., Troll W. Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors. Cancer Res. 47:1987;3159-3162.
94. German J. Bloom's Syndrome. Dermatol. Clin. 13:1995;7-18.
95. Gertler A., Nitsan Z. The effect of trypsin inhibitors on pancreotopeptidase E, trypsin, chymotrypsin, and amylase in the pancreas and intestinal tract of chicks receiving raw and heated soya bean diets. B. J. Nutr. 24:1970;803-804.
96. Gold E.B., Gordis L., Diener M.D., Seltser R., Boitnott J.K., Bynum T.E., Hutcheon D.F. Diet and other risk factors for cancer of the pancreas. Cancer. 55:1985;460-467.
97. Goldfarb R.H., Kitson R.P., Giffen C.Z., Yavelow J. Anticarcinogenic and anti-proteolytic Bowman-Birk Inhibitor (Bbi). failure to inhibit both LAK cell proteases and LAK cell-mediated killing of tumor cells Proc. Am. Assoc. Cancer Res. 30:1989;179.
98. Goldstein B.D., Witz G., Amoruso M., Troll W. Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption. Biochem. Biophys. Res. Commun. 88:1979;854-860.
99. Gorrill A.D.L., Thomas J.W. Body weight changes, pancreas size and enzyme activity, and proteolytic enzyme activity and protein digestion in intestinal contents from calves fed soybean and milk protein diets. J. Nutr. 92:1967;215-223.
100. Gottesman, M. N. (1987) Regulation by proteolysis. In: Escherichia coli and Salmonella typhimurium, pp. 1308-1312, Neidhardt, F. (ed.) American Society for Microbiology, Washington, DC.
101. Grau, C. R. and Carroll, R. W. (1958) Evaluation of protein quality. In: Processed Plant Protein Foodstuffs, Ch. 7, pp. 153-189, Altschul, A. M. (ed.) Academic Press, New York.
102. Green G.M., Lyman R.L. Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor induced hypersecretion in rats. Proc. Soc. Exp. Biol. Med. 140:1972;6-12.
103. Green G.M., Olds B.O., Matthews G., Lyman R.L. Protein as a regulator of pancreatic enzyme secretion in the rat. Proc. Soc. Exp. Biol. Med. 142:1973;1162-1167.
104. Green T.R., Ryan C.A. Wound-induced proteinase inhibitor in plant leaves. a possible defense mechanism against insects Science. 175:1972;776-777.
105. Grobstein, C., Cairns, J., Broitman, S. A., Campbell, T. C., Gussow, J. D., Kolonel, L. N., Kritchevsky, D., Mertz, W., Miller, A. B., Prival, M. J., Slaga, T., Wattenberg, L. and Sugimura, T. (1982) Diet, Nutrition and Cancer. Committee on Diet, Nutrition and Cancer, pp. 1-1-18-16, Assembly of Life Sciences, National Research Council, National Academy of Sciences, Washington, DC.
106. Gumbmann M.R., Spangler W.L., Dugan G.M., Rackis J.J., Liener I.E. The USDA trypsin inhibitor study, IV. the chronic effects of soyflour and soy protein isolate in rats after two years Qual. Plant Food Hum. Nutr. 35:1985;275-314.
107. Gumbmann M.R., Dugan G.M., Spangler W.L., Barker E.C., Rackis J.J. Pancreatic response in rats and mice to trypsin inhibitors from soy and potato after short and long term dietary exposure. J. Nutr. 199:1989;1598-1609.
108. Habres J.M., Billings P.C. Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors. Cancer Lett. 63:1992;135-142.
109. Haenszel, W. and Kurihara, M. (1968) Studies of Japanese immigrants. I. Mortality from cancer and other diseases among Japanese in the U.S. J. Natl. Cancer Inst. 40: 43-69.
110. Hanauer S.B., Baert F. Medical therapy of inflammatory bowel disease. Med. Clin. North Am. 78:1994;1413-1426.
111. Harlan J.M., Killen P.D., Harker L.A., Striker G.E., Wright D.G. Neutrophil-mediated endothelial injury in vitro. mechanisms of cell detachment J. Clin. Invest. 68:1981;1394-1403.
112. Hasdai A., Liener I.E. Growth, digestibility, and enzymatic activities in the pancreas and intestines of hamsters fed raw and heated soy flour. J. Nutr. 113:1983;662-668.
113. 1) mice. J. Natl. Cancer Inst. 75:1985;975-984.
114. Hawkins J.V., Emmel E.L., Feuer J.J., Nedelman M.A., Harvey C.J., Klein H.S., Rozmiarek H., Kennedy A.R., Lichtenstein G.R., Billings P.C. Protease activity in a hapten-induced model of ulcerative colitis in rats. Dig. Dis. 42:1997;1969-1980.
115. Heilbronn R., Schlehofer J.R., Yalkinoglu A.O., Zur Hausen H. Selective DNA amplification induced by carcinogens (initiators). evidence for a role of proteases and DNA polymerase alpha Int. J. Cancer. 36:1985;85-91.
116. Hirahara F., Miyagi Y., Miyagi E., Yasumitsu H., Koshikawa N., Nagashima Y., Kitamura H., Minaguchi H., Umeda M., Miyazaki K. Trypsinogen expression in human ovarian carcinomas. Int. J. Cancer. 63:1995;176-181.
117. Hooks R.D., Hays V.W., Speer V.C., McCall J.T. Effects of raw soybeans on pancreatic enzyme concentrations and performance of pigs. Fed. Proc. Fed. Am. Soc. Exp. Biol. 24:1965;894.
118. Horoszewicz J.S., Leong S.S., Kawinski E., Karr J.P., Rosenthal H., Chu G.M., Mirand E.A., Murphy G.P. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1983;1809-1818.
119. Hozumi M., Ogawa M., Sugimura T., Takeuchi T., Umezawa H. Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from actinomycetes. Cancer Res. 32:1972;1725-1728.
120. Hwang D.L.R., Davis-Lin K.T., Yang W.K., Foard D.T. Purification, partial characterization and immunological relationships of multiple low molecular weight proteinase inhibitors of soybean. Biochem. Biophys. Acta. 495:1977;369-382.
121. Hu E., Mueller E., Oliviero S., Papaioannou V.E., Johnson A., Spiegelman B.M. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13:1994;3094-3103.
122. Inoue M., Kishimoto A., Takai Y., Nishizuka Y. Studies on a cyclid nucleotide-independent protein kinase and its proenzyme in mammalian tissues. J. Biol. Chem. 252:1977;7610-7616.
123. Ishiura S. Calcium-dependent neutral protease from chicken skeletal muscle. I. Purification and characterization. J. Biochem. 84:1981;225-230.
124. Jochum M., Witte J., Schiessler H., Fritz H. Clotting and other plasma factors in septicemia. inhibition of degradation by an exogenous protease inhibitor from soybeans (type: Bowman-Birk). B.7. Fibrinolytic system Protids Biol. Fluids. 28:1981;417-420.
125. Jochum M., Duswald K.-H., Neumann S., Witte J., Fritz H. Poteinases and their inhibitors in septicemia - basic concepts and clinical implications. Adv. Exp. Med. Biol. 167:1984;391-404.
126. Kakade M.L., Barton T.L., Schaible P.J., Evan R.J. Biochemical changes in the pancreas of chicks fed raw soybeans and soybean meal. Poult. Sci. 46:1967;1578-1585.
127. Kakade M.L., Hoffa D.E., Liener I.E. Contribution of trypsin inhibitors to the deleterious effects of unheated soybeans fed to rats. J. Nutr. 103:1973;1772-1778.
128. Kakade M.L., Thompson R.D., Englestad W.W., Behrens G.C., Yoder R.D., Crave F.M. Failure of soybean trypsin inhibitors to exert deleterious effects in calves. J. Dairy Sci. 59:1976;1484-1489.
129. Kamiya K., Yasukawa-Barnes J., Mitchen J.M., Gould M.N., Clifton K.H. Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion. Proc. Natl. Acad. Sci. USA. 92:1995;1332-1336.
130. Kassell B. Trypsin and chymotrypsin inhibitors from soybeans. Methods Enzymol. 19:1970;853-862.
131. Kelenyi G. Changes in mast cells following x-irradiation. Acta Morphol. 3:1953;377-381.
132. Kelloff G.J., Johnson J.R., Crowell J.A., Boone C.W., DeGeorge J.J., Steele V.E., Mehta M.U., Temeck J.W., Schmidt W.J., Burke G., Greenwald P., Temple R.J. Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol. Biomarkers Prev. 4:1995;1-10.
133. Kennedy A.R. Antipain, but not cycloheximide, suppresses radiation transformation when present for only one day at five days post-irradiation. Carcinogenesis. 3:1982;1093-1095.
134. Kennedy, A. R. (1984) Promotion and other interactions between agents in the induction of transformation in vitro in fibroblasts. In: Mechanisms of Tumor Promotion, Vol. III, Tumor Promotion and Carcinogenesis In Vitro, Ch. 2, pp. 13-55, Slaga, T. J. (ed.) CRC Press, Inc., Boca Raton.
135. Kennedy A.R. The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitors. Carcinogenesis. 6:1985;1441-1446. a.
136. Kennedy, A. R. (1985b) Evidence that the first step leading to carcinogen-induced malignant transformation is a high frequency, common event. In: Carcinogenesis; A Comprehensive Survey, Vol. 9, Mammalian Cell Transformation: Mechanisms of Carcinogenesis and Assays for Carcinogens, pp. 355-364, Barrett, J. C. and Tennant, R. W. (eds.) Raven Press, New York.
137. Kennedy, A. R. (1988) Implications for mechanisms of tumor promotion and its inhibition by various agents from studies of in vitro transformation. In: Tumor Promoters, Biological Approaches for Mechanistic Studies and Assay Systems, pp. 201-212, Langenbach, R., Barrett, J. C. and Elmore, E. (eds.) Raven Press, New York.
138. Kennedy, A. R. (1989) Initiation and promotion of radiation induced transformation in vitro: relevance of in vitro studies to radiation induced cancer in human populations. In: Cell Transformation and Radiation-Induced Cancer, Ch. 7, pp. 263-270, Chadwick, K. H., Seymour, C. and Barnhart, B. (eds.) IOP Publishing, Ltd (Adam Hilger), Bristol.
139. Kennedy, A. R. (1990) Effects of protease inhibitors and vitamin E in the prevention of cancer. In: Nutrients and Cancer Prevention, pp. 79-98, Prasad, K. N. and Meyskens, F. L., Jr. (eds.) The Humana Press, Inc., Clifton.
140. Kennedy A.R. Is there a critical target gene for the first step in carcinogenesis? Environ. Health Perspect. 93:1991;199-203.
141. Kennedy, A. R. (1993a) Overview: anticarcinogenic activity of protease inhibitors. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 9-64, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
142. Kennedy, A. R. (1993b) In vitro studies of anticarcinogenic protease inhibitors. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 65-91, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
143. Kennedy A.R. Cancer prevention by protease inhibitors. Prev. Med. 22:1993;796-811. c.
144. Kennedy, A. R. (1993d) The impact of protease inhibitors from soybeans on the carcinogenic process. In: Adjuvant Nutrition in Cancer Treatment, pp. 129-144, Quillin, P. and Williams. R. M. (eds.) Cancer Treatment Research Foundation, Arlington Heights.
145. Kennedy, A. R. (1993e) Potential mechanisms of antitumorigenesis by protease inhibitors. In: Antimutagenesis and Anticarcinogenesis: Mechanisms, Vol. 3, pp. 301-308, Bronzetti, G., Hayatsu, A., DeFlora, S., Waters, M. D. and Shankel, D. M. (eds.) Plenum Publishing Corporation, New York and London.
146. Kennedy A.R. Use of cell and organ cultures in the identification and characterization of agents that modify carcinogenesis. Cancer Res. 53(Suppl.):1993;2446s-2448s. f.
147. Kennedy A.R. Prevention of carcinogenesis by protease inhibitors. Cancer Res. 54(Suppl.):1994;1999s-2005s.
148. Kennedy A.R. The evidence for soybean products as cancer preventive agents. J. Nutr. 125(Suppl.):1995;733s-743s. a.
149. Kennedy, A. R. (1995b) Mechanisms of cancer prevention: effects of protease inhibitors on proteases and gene expression. In: Nutrients in Cancer Prevention and Treatment, pp. 71-82, Prasad, K. N., Santamaria, L. and Williams, R. M. (eds.) The Humana Press, Inc., Clifton.
150. Kennedy A.R. Letter to the editor. J. Nutr. 126:1996;584-585. a.
151. Kennedy A.R. Is a mutagenic event involved in radiation induced malignant transformation? Mutat. Res. 350:1996;81-91. b.
152. Kennedy, A. R. and Billings, P. C. (1987) Anticarcinogenic actions of protease inhibitors. In: Anticarcinogenesis and Radiation Protection, pp. 285-295, Cerutti, P. A., Nygaard, O. F. and Siomic, M. G. (eds.) Plenum Press, New York.
153. Kennedy A.R., Little J.B. Protease inhibitors suppress radiation induced malignant transformation in vitro. Nature. 276:1978;825-826.
154. Kennedy A.R., Little J.B. Investigation of the mechanism for the enhancement of radiation transformation in vitro by TPA. Carcinogenesis. 1:1980;1039-1047.
155. Kennedy A.R., Little J.B. Effects of protease inhibitors on radiation transformation in vitro. Cancer Res. 41:1981;2103-2108. a.
156. Kennedy A.R., Little J.B. High efficiency, kinetics and numerology of transformation by radiation in vitro. Burchenal J.H., Oettgen J.F. Achievements, Challenges and Prospects for the 1980's, Vol. 1. 1981;491-500 Grune and Stratton Inc, New York. b.
157. Kennedy A.R., Little J.B. Evidence that a second event in X-ray induced oncogenic transformation in vitro occurs during cellular proliferation. Radiat. Res. 99:1984;228-248.
158. Kennedy A.R., Manzone H. Effects of protease inhibitors on levels of proteolytic activity in normal and pre-malignant cells and tissues. J. Cell. Biochem. 22(Suppl.):1995;188-194.
159. Kennedy A.R., Weichselbaum R.R. Effects of 17-β-estradiol on radiation transformation in vitro. inhibition of effects by protease inhibitors Carcinogenesis. 2:1981;67-79.
160. Kennedy A.R., Fox M., Murphy G., Little J.B. Relationship between X-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc. Natl. Acad. Sci. USA. 77:1980;7262-7266.
161. Kennedy A.R., Cairns J., Little J.B. Timing of the steps in transformation of C3H10T1/2 cells by X-irradiation. Nature. 307:1984;85-86. a.
162. Kennedy A.R., Radner B., Nagasawa H. Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with Bloom syndrome. Proc. Natl. Acad. Sci. USA. 81:1984;1827-1830. b.
163. Kennedy A.R., Billings P.C., Maki P.A., Newberne P. Effects of various protease inhibitor preparations on oral carcinogenesis in hamsters induced by 7,12-dimethylbenz(a)anthracene. Nutr. Cancer. 19:1993;191-200. a.
164. Kennedy A.R., Szuhaj B.F., Newberne P.M., Billings P.C. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr. Cancer. 19:1993;281-302. b.
165. Kennedy A.R., Beazer-Barclay Y., Kinzler K.W., Newberne P.M. Suppression of carcinogenesis in the intestines of Min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res. 56:1996;679-682.
166. Kennedy C.W., Donahue J.J., Wan X.S. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum. Nutr. Cancer. 26:1996;209-217.
167. 1-antichymotryspin. J. Immunol. 146:1991;2388-2393.
168. Kim J., Baker D.G., Hahn S.S., Goodchild N.T., Constable W.C. Topical use of N-acetylcysteine for reduction of skin reaction to radiation therapy. Semin. Oncol. 10:1983;86-92.
169. Korbelik M., Osmak M., Suhar A., Skrk J., Turk V., Petrovic D. Modification of potentially lethal damage repair by some intrinsic intra- and extracellular agents. I. Proteinases and proteinase inhibitors Int. J. Radiat. Biol. 54:1988;461-474.
170. Koshikawa N., Yasumitsu H., Nagashima Y., Umeda M., Miyazaki K. Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line. Biochem. J. 303:1994;187-190.
171. Kunitz M. Crystalline soybean trypsin inhibitor. J. Gen. Physiol. 30:1947;291-310.
172. Kuroki T., Drevon C. Inhibition of chemical transformation in C3H/10T1/2 cells by protease inhibitors. Cancer Res. 39:1979;2755-2761.
173. 1-antichymotrypsin and human leukocyte cathepsin G. complex formation and production of a modified inhibitor Biochem. Biophys. Res. Commun. 105:1982;186-193.
174. Land H., Parada L.F., Weinberg R.A. Cellular oncogenes and multistep carcinogenesis. Science. 222:1983;771-778. a.
175. Land H., Prada L.F., Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 304:1983;596-602. b.
176. Larionova, N. I., Gladysheva, I. P., Tikhonova, T. V. and Kazanskaya, N. F. (1994a) Inhibition of cathepsin G and human granulocyte elastase by multiple forms of Bowman-Birk type soybean inhibitor. (translated from Russian) Biokhimiya 58: 1437-1444 (1993).
177. Larionova N.I., Topchieva I.N., Gladysheva I.P., Kennedy A.R. The Bowman-Birk inhibitor-polyester conjugate. synthesis, inhibition of serine proteinases and suppression of radiation transformation in vitro Cancer J. 7:1994;158-163. b.
178. Lavi S. Carcinogen-mediated amplification of viral DNA sequences in Simian virus 40-transformed Chinese hamster embryo cells. Proc. Natl. Acad. Sci. USA. 78:1981;6144-6148.
179. Lavi S. Carcinogen-mediated amplification of specific DNA sequence. J. Cell. Biochem. 18:1986;149-156.
180. Leb L., Beatson P., Fortier N., Newburger P.E., Snyder L.M. Modulation of mononuclear phagocyte cytotoxicity by alpha-tocopherol (vitamin E). J. Leukoc. Biol. 37:1985;449-459.
181. Lee H.P., Gourley L., Duffy S.W., Esteve J., Lee J., Day N.E. Dietary effects of breast-cancer risk in Singapore. Lancet. 337:1991;1197-1200.
182. Lee J.K., Park B.J., Yoo K.Y., Ahn Y.O. Dietary factors and stomach cancer. a case-control study in Korea Int J. Epidemiol. 24:1995;33-41.
183. Lee J.S., Brown W.E., Pearce G., Dreher T.W., Graham J.S., Ahern K.G., Pearson G.D., Ryan C.A. Molecular characterization and phylogenetic studies with a wound-inducible protease inhibitor gene in Lycopersicum species. Proc. Natl. Acad. Sci. USA. 83:1986;7277-7281.
184. Li J.H., Billings P.C., Kennedy A.R. Induction of oncogene expression by sodium arsenite in C3H/10T1/2 cells; inhibition of c-myc expression by protease inhibitors. Cancer J. 5:1992;354-358.
185. Liddle R.A., Goldfine I.D., Williams J.A. Bioassay of plasma cholecystokinin in rats. effects of food, trypsin inhibitor and alcohol Gastroenterology. 87:1984;542-549.
186. Liebner E.J., Moos W.S., Hochhauser M., Harvey R.A. Lowering the skin temperature of the irradiated field. Am. J. Roentgenol. Radium Ther. Nucl. Med. 88:1962;976-987.
187. Liener I.E. Significance for humans of biologically active factors in soybeans and other food legumes. J. Am. Oil Chemists Soc. 56:1979;121-129. a.
188. Liener I.E. Protease inhibitors and lectins. Veuberger A., Jakes T.H. International Review of Biochemistry. 1979;97-122 University Park Press, Baltimore. b.
189. Liener, I. E. (1989) Control of anti-nutritional and toxic factors in oilseeds and legumes. In: Food Uses of Whole Oil and Protein Seeds, Ch. 22, pp. 344-371, Lusas, E. W., Erikson, D. R. and Nip, W.-K. (eds.) American Oil Chemists Society, Champaign.
190. Liener I.E., Hasdai A. The effect of long-term feeding of raw soy flour on the pancreas of mouse and hamster. Adv. Exp. Med. Biol. 199:1986;189-197.
191. Liener, I. E. and Kakade, M. L. (1980) Protease inhibitors. In: Toxic Constituents of Plant Foodstuffs, pp. 7-71. Liener, I. E. (ed.) Academic Press, New York.
192. Liener I.E., Goodale R.L., Deshmukh A., Satterberg T.L., Ward G., Dipietro C.M., Bankey P.E., Borner J.W. Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas. Gastroenterology. 94:1988;419-427.
193. Lim T.S., Putt N., Safranski D., Chung C., Watson R.R. Effect of vitamin E on cell-mediated immune responses and serum corticosterone in young and maturing mice. Immunology. 44:1981;289-295.
194. Lippman S.M., Lee J.S., Lotan R., Hittelman W., Wargovich M.J., Hong W.K. Biomarkers as intermediate endpoints in chemoprevention trials. J. Natl. Cancer Inst. 82:1990;555-560.
195. Little J.W., Edmiston S.H., Pacelli L.Z., Mount D.W. Cleavage of the Escherichia coli lexA protein by the recA protease. Proc. Natl. Acad. Sci. USA. 77:1980;3225-3229.
196. Long S., Quigley J., Troll W., Kennedy A.R. Protease inhibitor antipain suppresses TPA induction of plasminogen activator in transformable mouse embryo fibroblasts. Carcinogenesis. 2:1981;933-936.
197. Lu L.-J.W., Anderson K.E., Gomez G., Nealon W.H. Decreased plasma levels of cholecystokinin in healthy males after chronic ingestion of a heat-treated soya product. Cancer Lett. 90:1995;149-155.
198. Lucibello F.C., Muller R. Proto-oncogenes encoding transcriptional regulations. unravelling the mechanisms of oncogenic conversion Crit. Rev. Oncog. 2:1991;259-276.
199. Mack, T. M. (1982) Pancreas. In: Cancer Epidemiology and Prevention, pp. 638-667, Schottenfeld, D. and Fraumeni, J. (eds.) W. B. Saunders Co., Philadelphia.
200. Mackay A.A., Ballin M., Pelina M.D., Farina A.R., Nason A.M., Hartzler J.L., Thorgeirsson U.P. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis. 12:1992;168-184.
201. Madar Z., Birk Y., Gertler A. Native and modified Bowman-Birk trypsin inhibitor - comparative effect on pancreatic enzymes upon ingestion by quails. Comp. Biochem. Physiol. 48B:1974;251-256.
202. Madar Z., Gertler A., Birk Y. The fate of the Bowman-Birk trypsin inhibitor from soybeans in the digestive tract of chicks. Comp. Biochem. Physiol. 62:1979;1057-1061.
203. Mainz D.L., Black O., Webster P.D. Hormonal control of pancreatic growth. J. Clin. Invest. 52:1973;2300-2304.
204. Maki P.A., Kennedy A.R. Humoral and cellular immune functions are not compromised by the anticarcinogenic Bowman-Birk inhibitor. Nutr. Cancer. 18:1992;165-173.
205. Maki P., Paterson Y., Kennedy A.R. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans. Nutr. Cancer. 22:1994;185-193.
206. Manzone H., Billings P.C., Cummings W.N., Feldman R., Clark L.C., Odell C.S., Horan A., Atiba J.O., Meyskens F.L. Jr., Kennedy A.R. Levels of proteolytic activities as intermediate marker endpoints in oral carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 4:1995;521-527.
207. Matrisian L.M., Glaichenhaus N., Gesnel M.C., Breathnach R. Isolation of the oncogene and epidermal growth factor-induced transin gene. complex control in rat fibroblasts Mol. Cell. Biol. 6:1986;1679-1686.
208. Matsushima, T., Kakizoe, T., Kawachi, T., Hara, K., Suzimura, T., Takeuchi, T. and Umezawa, H. (1976) Effects of protease inhibitors of microbiol origin on experimental carcinogenesis. In: Fundamentals in Cancer Prevention, pp. 57-69, Magee, P. N., Takayama, S., Sugimura, T. and Matsushima, T. (eds.) University Park Press, Baltimore.
209. McGuiness E.E., Morgan R.G.H., Levison D.A., Frape D.L., Hopwood D., Wormsley K.G. The effect of long-term feeding of soya flour on the rat pancreas. J. Scand. Gastroenterol. 15:1980;497-502.
210. McGuiness E.E., Morgan R.G.H., Wormsley K.G. Effects of soybean flour on the pancreas of rats. Environ. Health Perspect. 56:1984;205-212.
211. Melmed R.N., El-Aaser A.A.A., Holt S.J. Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitor. Biochem. Biophys. Acta. 421:1976;280-282.
212. Messadi D.V., Billings P., Shklar G., Kennedy A.R. Inhibition of oral carcinogenesis by a protease inhibitor. J. Natl. Cancer Inst. 76:1986;447-452.
213. Messina, M. J. (ed.) (1995) Proceedings of the First International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Mesa, AZ, Feb. 20-24, 1991. J. Nutr. 125 (Suppl.).
214. Messina, M. J. (ed.) (1995) Proceedings of the First International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Mesa, AZ, Feb. 20-24, 1991. J. Nutr. 125 (Suppl.).
215. Messina M., Barnes S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 83:1991;541-546.
216. Messina M.J., Persky V., Setchell K.D.R., Barnes S. Soy intake and cancer risk. a review of the in vitro and in vivo data Nutr. Cancer. 21:1994;113-131.
217. Metropolitan Insurance Companies (1992) International longevity comparisons. Statistical Bulletin - Metropolitan Insurance Companies 73: 10-15.
218. Meyn M.S., Rossman T., Troll W. A protease inhibitor blocks SOS functions in Escherichia coli. antipain prevents λ repressor inactivation, ultraviolet mutagenesis and filamentous growth Proc. Natl. Acad. Sci. USA. 74:1977;1152-1156.
219. Mills P.K., Beeson W.L., Abbey D.E., Fraser G.E., Phillips R.L. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer (Phila.). 61:1988;2578-2585.
220. Miyasaka K., Green G.M. Effect of partial exclusion of pancreatic juice on rat basal pancreatic secretion. Gastroenterology. 86:1984;114-119.
221. Miyasaka K., Nakamura R., Funakoshi A., Kitani K. Stimulatory effect of monitor peptide and human pancreatic secretory trypsin inhibitor on pancreatic secretion and cholecystokinin release in conscious rats. Pancreas. 4:1989;139-144.
222. Mizutani H., Schechter N.M., Lazarus G., Black R.A., Kupper T.S. Rapid and specific conversion of precursor interleukin 1β (Il-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174:1991;821-825.
223. Morgan, R. G. H. (1987) Raw soy flour and pancreatic cancer in experimental animals. In: Experimental Pancreatic Carcinogenesis, pp. 159-174, Scarpelli, D. G., Reddy, J. K. and Longnecker, D. S. (eds.) CRC Press, Inc., Boca Raton.
224. Morgan R.G.H., Levinson D.A., Hopwood D., Saunders J.H.B., Wormsley K.G. Potentiation of the action of azaserine on the rat pancreas by raw soyabean flour. Cancer Lett. 3:1977;87-90.
225. Muller R., Bravo R., Burckhardt J., Curran T. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature. 312:1984;716-720.
226. Myers B.A., Hathcock J., Shiekh N., Roebuck B.D. Effects of dietary soya bean trypsin inhibitor concentrate on initiation and growth of putative preneoplastic lesions in the pancreas of the rat. Food Chem. Toxicol. 29:1991;437-443.
227. Naim M., Gertler A., Birk Y. The effect of dietary raw and autoclaved soya-bean protein fractions on growth, pancreatic enlargement and pancreatic enzymes in rats. Br. J. Nutr. 47:1982;281-288.
228. National Toxicology Program Technical Report on the Comparative Toxicology Studies of Corn Oil, Safflower Oil and Tricaprylin (CAS Nos. 8001-30-7, 8001-23-8 and 538-23-8) in Male F344/N Rats as Vehicles for Gavage, National Toxicology Program, P.O. Box. 12233,(Research Triangle Park, NC 27709 (NTP TR 426; NIH Publication No. 94-3157)):1994.
229. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature. 308:1984;693-698.
230. Nitsan Z., Alumot E. Overcoming the inhibition of intestinal proteolytic activity caused by raw soybean in chicks of different ages. J. Nutr. 84:1964;179-184.
231. Nitsan Z., Nir I. A comparative study of the nutritional and physiological significance of raw and heated soybeans in chicks and goslings. J. Nutr. 37:1977;81-91.
232. Nomura T., Hata S., Enomoto T., Tanaka H., Shibata K. Inhibiting effects of antipain on urethane induced lung neoplasia in mice. Br. J. Cancer. 42:1980;624-626.
233. Noonan N.E., Noonan K.D. The effect of TLCK on transcription and its role in modifying cell growth. J. Cell. Physiol. 92:1977;137-144.
234. Norell S.E., Ahlbom A., Erwald R., Jacobson G., Lindberg-Navier I., Olin R., Tornberg B., Wiechel K.L. Diet and pancreatic cancer. a case-control study Am. J. Epidemiol. 124:1986;894-902.
235. Odani S., Ikenaka T.J. Scission of soybean Bowman-Birk proteinase inhibitor into two small fragments having either trypsin or chymotrypsin inhibitor activity. J. Biochem. (Tokyo). 74:1973;857-860.
236. Ohkoshi M., Fujii S. Effect of the synthetic protease inhibitor N1N-dimethylcarbamoylmethyl 34-(4-guanidinobenzoyloxy) phenylacetate methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin. J. Natl. Cancer Inst. 71:1983;1053-1057.
237. Ohlsen L., Evers H., Segerstrom K., Hagelquist E., Graffman S. Local anaesthetics modifying the dermal response of radiation. Acta Oncol. 26:1987;467-476.
238. Oreffo V.I.C., Billings P.C., Kennedy A.R., Witschi H. Acute effects of the Bowman-Birk protease inhibitor in mice. Toxicology. 69:1991;165-176.
239. Osborne T.B., Mendel L.B. The use of soybean as food. J. Biol. Chem. 32:1917;369-387.
240. Palladino M.A., Galton J.E., Troll W., Thorbecke G.J. Gamma irradiation-induced mortality. protective effect of protease inhibitors in chickens and mice Int. J. Radiat. Biol. 41:1982;183-191.
241. Patten J.R., Richards E.A., Wheeler J. The effect of raw soybean on the pancreas of adult dogs. Proc. Soc. Exp. Biol. Med. 137:1971;58. a.
242. Patten J.R., Richards E.A., Wheeler J. The effect of dietary soybean trypsin inhibitor on the histology of dog pancreas. Life Sci. 10:1971;145-150. b.
243. Patten J.R., Patten J.A., Pope H. Sensitivity of the guinea pig to raw soya bean in the diet. Food Cosmet. Toxicol. 11:1973;577-583.
244. Pena, A. S., Shivanada, S. and Mayberry, J. F. (1991) Epidemiology of ulcerative colitis. In: Ulcerative Colitis, pp. 1-8, O'Morain, C. A. (ed.) CRC Press, Boca Raton.
245. Permert J., Kazakoff K., Pour P.M., Adrian E.E. Effect of CCK receptor blockade on pancreatic tumor initiation in hamsters fed raw soya diet. Gastroenterology. 104:1993;A1042.
246. Persiani S., Yeung A., Shen W.C., Kennedy A.R. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anticarcinogenic agents. Carcinogenesis. 12:1991;1149-1152.
247. Phillips R.L. Role of lifestyle and dietary habits in risk of cancer among Seventh Day Adventists. Cancer Res. 35:1975;3515-3522.
248. Phillips R.L., Garfinkel L., Kuzma J.W., Beeson W.L., Lotz T., Brin B. Mortality among California Seventh-Day Adventists for selected cancer sites. J. Natl. Cancer Inst. 65:1980;1097-1107.
249. Pineda, O., Torun, B., Viteri, F. E. and Arroyave, G. (1982) Protein quality in relation to estimates of essential amino acid requirements. In: Protein Quality in Humans: Assessment and In Vitro Estimation, pp. 29-42, Bodwell, C. E., Adkins, J. S. and Hopkins, D. T. (eds.) AVI Publishing Co., Westport.
250. Potera M.E., Lookingbill D.P., Stryker J.A. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiology. 143:1982;775-777.
251. Pour P.M. Modification of tumor development in the pancreas. Prog. Exp. Tumor Res. 33:1991;108-131.
252. Rackis J.J., Anderson R.L. Isolation of four soybean trypsin inhibitors by DEAE-cellulose chromatography. Biochem. Biophys. Res. Commun. 15:1964;230-235.
253. Rackis J.J., McGhee J.E., Booth A.N. Biological threshold levels of soybean trypsin inhibitor by rat bioassay. Cereal Chem. 52:1975;84-93.
254. Rackis J.J., Wolf W.J., Baker E.C. Protease inhibitors in plant foods. content and inactivation Adv. Exp. Med. Biol. 199:1986;299-347.
255. Reznikoff C.A., Brankow D.W., Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to post-confluence inhibition of cell division. Cancer Res. 33:1973;3231-3238.
256. Richter B.D., Schneeman B.O. Pancreatic response to long-term feeding of soy protein isolate, casein or egg white in rats. J. Nutr. 117:1987;247-252.
257. Robbins D.J., Liener I.E., Spangler W.M., de Bruyn D.B. The effects of a raw soy protein diet on the pancreas of the Chacma baboon. Nutr. Rep. Int. 38:1988;9-16.
258. Roebuck, B. D. and Longnecker, D. S. (1993) Protease inhibitors and pancreatic carcinogenesis. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 295-301, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
259. Roebuck B.D., Kaplita P.V., Edwards B.R., Praissman M. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Cancer Res. 47:1987;1333-1338.
260. Rosen A., Klein G. UV light-induced immunoglobulin heavy-chain class switch in a human lymphoblastoid cell line. Nature. 306:1983;189-190.
261. Rossman T.G., Klein C.B. Mammalian SOS system. a case of misplaced analogies Cancer Invest. 3:1985;175-187.
262. Rossman, T. G. and Troll, W. (1980) Protease inhibitors in carcinogenesis: possible sites of action. In: Carcinogenesis: Modifiers of Chemical Carcinogenesis, Vol. 5, pp. 127-143, Slaga, T. J. (ed.) Raven Press, New York.
263. Rothman S.S., Wells H. Enhancement of pancreatic enzyme synthesis by pancreozymin. Am. J. Physiol. 213:1967;215-218.
264. α-deficient mice. Nat. Genet. 10:1995;143-150.
265. Russo J., Calaf G., Russo I.H. A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens. Crit. Rev. Oncog. 4:1993;403-417.
266. Ryan C.A., Kassell B. Chymotrypsin inhibitor I from potatoes. Methods Enzymol. 19:1970;883-889.
267. 84 bond by mast cell chymase. J. Biol. Chem. 269:1994;18134-18140.
268. Sale J.K., Goldberg D.M., Fawcett A.N., Wormsley K.G. Chronic and acute studies indicating absence of exocrine pancreatic feedback inhibition in dogs. Digestion. 15:1977;540-555.
269. Sawey M.J., Hood A.T., Burns F.J., Garte S.J. Activation of myc and ras oncogenes in primary rat tumors induced by ionizing radiation. Mol. Cell. Biol. 7:1987;932-935.
270. Schechter N.M., Sprows J.L., Schoenberger O.L., Lazarus G.S., Cooperman B.S., Rubin H. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J. Biol. Chem. 264:1989;21308-21315.
271. Schelp F.P., Pongpaew P. Protection against cancer through nutritionally-induced increase in endogenous proteinase inhibitors - a hypothesis. Int. J. Epidemiol. 17:1988;287-292.
272. Schingoethe D.J., Aust S.D., Thomas J.W. Separation of a mouse growth inhibitor in soybeans from trypsin inhibitors. J. Nutr. 100:1970;739-748.
273. Schonthal A., Herrlich P., Rahmsdorf H.J., Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell. 54:1988;325-334.
274. Scott R.E., Maercklein P.B. An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation. a concept that initiation of carcinogenesis involves multiple phases Proc. Natl. Acad. Sci. USA. 82:1985;2995-2999.
275. Scrimshaw N.S., Wayler A.H., Murray E., Steinke F.H., Rand W.M., Young V.R. Nitrogen balance response in young men given one or two isolated soy proteins or milk proteins. J. Nutr. 113:1983;2492-2497.
276. Senda S., Fujiyama Y., Bamba T., Hosoda S. Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor. Intern. Med. 32:1993;350-354.
277. Severson R.K., Nomura A.M.Y., Grove J.S., Stemmermann G.N. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 49:1989;1857-1860.
278. Shasby D.M. Antioxidant activity of some antiproteases. Am. Rev. Resp. Dis. 131:1985;293-294.
279. Shen W.C., Wan J., Shen D. Proteolytic processing in a non-lysosomal compartment is required for transcytosis of protein-polylysine conjugates in cultured Madin-Darby canine kidney cells. Biochem. Biophys. Res. Commun. 166:1990;316-323.
280. Silverman J., Adams J.O. N-Nitrosamines in laboratory animal feed and bedding. Lab. Anim. Sci. 33:1983;161-164.
281. Sipos E. Dietary trends for vegetable proteins in foods. Inform. 1:1990;753-757.
282. Slaga T.J., Klein-Szanto A.J.P., Fischer S.M., Weeks C.E., Nelson K., Major S. Studies on the mechanism of action of anti-tumor-promoting agents. their specificity in two-stage promotion Proc. Natl. Acad. Sci USA. 77:1980;2251-2254.
283. Smirnoff P., Khalef S., Birk Y., Applebaum S.W. Trypsin and chymotrypsin inhibitor from chick peas. Int. J. Pept. Protein Res. 14:1979;186-192.
284. Solomon D.H., O'Brian C.A., Weinstein I.B. N-α-tosyl-L-lysine chloromethyl ketone and N-α-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C. FEBS Lett. 190:1985;342-344.
285. Soule H.D., Maloney T.M., Wolman S.R., Peterson W.D. Jr., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:1990;6075-6086.
286. Soy Protein Council (1987) Soy Protein Products: Characteristics, Nutritional Aspects and Utilization, pp. 7-13. Washington, DC.
287. Spangler W.L., Gumbmann M.R., Liener I.E., Rackis J.J. The USDA Trypsin Inhibitor Study III. Sequential development of pancreatic pathology in rats. Qual. Plant Foods Hum. Nutr. 35:1985;259-274.
288. St. Clair W.H. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor. Carcinogenesis. 12:1991;935-937.
289. St. Clair W.H., St. Clair D.K. Effect of the Bowman-Birk protease inhibitor on the expression of oncogenes in the irradiated rat colon. Cancer Res. 51:1991;4539-4543.
290. St. Clair W., Billings P., Carew J., Keller-McGandy C., Newbene P., Kennedy A.R. Suppression of DMH-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res. 50:1990;580-586. a.
291. St. Clair W.H., Billings P.C., Kennedy A.R. The effects of the Bowman-Birk protease inhibitor on c-myc expression and cell proliferation in the unirradiated and irradiated mouse colon. Cancer Lett. 52:1990;145-152. b.
292. St. Clair W.H., St. Clair D.K., Kennedy A.R. Comparison of the Bowman-Birk protease inhibitor to WR1065 for protection against radiation-induced DNA, cellular and tissue damage. Cancer J. 4:1991;278-282.
293. Ha oncogene and form papillomas in skin grafts on athymic nude mice host. Cancer Res. 48:1988;165-169.
294. Struthers B.J., MacDonald J.R., Dahlgren R.R., Hopkins D.T. Effects on the monkey, pig and rat pancreas of soy products with varying levels of trypsin inhibitor and comparison with the administration of cholecystokinin. J. Nutr. 113:1983;86-97.
295. Su L.N., Toscano W.A. Jr., Kennedy A.R. Suppression of phorbol ester-enhanced radiation-induced malignancy in vitro by protease inhibitors is independent of protein kinase C. Biochem. Biophys. Res. Commun. 176:1991;18-24.
296. Su Z.Z., Yemul S., Stein C.A., Fisher P.B. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation. Oncogene. 10:1995;2037-2049.
297. Sugita H., Ishiura S., Suzuki K., Imahori K. Inhibition of epoxide derivatives on chicken calcium-activated neutral protease (Canp) in vitro and in vivo. J. Biochem. 87:1980;339-341.
298. Swartz L.B., Austen K.F. Structure and function of the chemical mediators of mast cells. Prog. Allergy. 34:1984;271-321.
299. Tait L., Soule H.D., Russo J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:1990;6087-6094.
300. Takai Y., Kishimoto A., Inoue M., Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. 1. Purification and characterization of an active enzyme from bovine cerebellum. J. Biol. Chem. 252:1977;7603-7609.
301. Takai Y., Kishimoto A., Iwasa M., Kawahara Y., Mori T., Nishizuka Y. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipid. J. Biol. Chem. 254:1979;3692-3695.
302. Takechi H., Hirayoshi K., Nakai A., Kudo H., Saga S., Nagata K. Molecular cloning of a mouse 47-kDa heat-shock protein (Hsp47), collagen-binding stress protein, and its expression during the differentiation of F9 teratocarcinoma cells. Eur. J. Biochem. 206:1992;323-329.
303. Taylor W.R., Egan S.E., Mowat M., Greenberg A.H., Wright J.A. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination. Oncogene. 7:1992;1383-1390.
304. Terzaghi-Howe M. Induction of preneoplastic alterations by X-rays and neutrons in exposed rat tracheas and isolated tracheal epithelial cells. Radiat. Res. 120:1989;352-363.
305. Tlsty T.O., Brown P.C., Schimke R.T. Ultraviolet radiation facilitates methotrexate resistance and amplification of the dihydrofolate reductase gene in cultured 3T6 mouse cells. Mol. Cell. Biol. 4:1984;1050-1056.
306. Tominaga S. Cancer incidence in Japanese in Japan, Hawaii, and Western United States. Natl. Cancer Inst. Monogr. 69:1985;83-92.
307. Torun, B., Pineda, O., Vireti, F. E. and Arrayave, G. (1982) Use of amino acid composition data to predict protein nutritive value for children with specific reference to new estimates for their essential amino acid requirements. In: Protein Quality in Humans: Assessment and In Vitro Evaluation, pp. 374-393, Bodwell, C. E., Adkins, J. S. and Hopkins, D. T. (eds.) AVI Publishing Co., Westport.
308. Toskes P.P. Negative feedback inhibition of pancreatic exocrine secretion in humans. Adv. Exp. Med. Biol. 199:1986;142-152.
309. Travis J., Salvesen G.S. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:1983;655-709.
310. Travis J., Bowen J., Baugh R. Human α-1-antichymotrypsin. interaction with chymotrypsin-like proteinases Biochemistry. 17:1978;5651-5656.
311. Troll, W. (1976) Blocking tumor promotion by protease inhibitors. In: Fundamentals in Cancer Prevention, pp. 41-55, Magee, P. M., Takayama, S., Sugimura, T. and Matsushima, T. (eds.) University Park Press, Baltimore.
312. Troll, W. and Kennedy, A. R. (eds.) (1993) Protease Inhibitors as Cancer Chemopreventive Agents. Plenum Publishing Corporation, New York and London.
313. Troll W., Klassen A., Janoff A. Tumorigenesis in mouse skin. inhibition by synthetic inhibitors of proteases Science. 169:1970;1211-1213.
314. Troll, W., Belman, S., Wiesner, R. and Shellabarger, C. J. (1979a) Protease action in carcinogenesis. In: Biological Functions of Proteinases, pp. 165-170, Holtzer, H. and Tschesche, H. (eds.) Springer-Verlag, Berlin, Heidelberg, New York.
315. Troll W., Weisner R., Belman S., Shellabarger C.J. Inhibition of carcinogenesis by feeding diets containing soybeans. Proc. Am. Assoc. Cancer Res. 20:1979;265. b.
316. Troll W., Weisner R., Shellabarger C.J., Holtzman S., Stone J.P. Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis. 1:1980;469-472.
317. Troll, W., Witz, G., Goldstein, B., Stone, D. and Sugimura, T. (1982) The role of free oxygen radicals in tumor promotion and carcinogenesis. In: Carcinogenesis: A Comprehensive Survey; Cocarcinogenesis and Biological Effects of Tumor Promoters, Vol. 7, pp. 593-597, Hecker, E., Fusenig, N. E., Kunz, W., Marks, F. and Theilmann, H. W. (eds.) Raven Press, New York.
318. Troll W., Frenkel K., Wiesner R. Protease inhibitors as anticarcinogens. J. Natl. Cancer Inst. 73:1984;1245-1250.
319. Umans R.S., Weichselbaum R.R., Johnson C.M., Kennedy A.R. Protease inhibitor antipain reduces nuclear binding of estrogen-receptor complex in MCF-7 breast tumor cells. Carcinogenesis. 5:1984;1355-1357.
320. Umans R.S., Radner B., Kennedy A.R. Effects of protease inhibitors on nuclear binding of glucocorticoid hormones in C3H10T1/2 cells. Fed. Eur. Biochem. Soc. 193:1985;27-30.
321. Umezawa K. Enzyme Inhibitors of Microbial Origin. 1972;University of Tokyo Press, Tokyo.
322. Verhey L.J., Sedlacek R. Determination of the radioprotective effects of topical applications of MEA, WR2721 and N-acetylcysteine on murine skin. Radiat. Res. 93:1983;175-183.
323. von Hofe, E., Brent, R. and Kennedy, A. R. (1990) Inhibition of X-ray induced exencephaly by protease inhibitors. Radiat. Res. 108-111.
324. von Hofe E., Newberne P.M., Kennedy A.R. Inhibition of N-nitrosomethylbenzylamine induced esophageal neoplasms by the Bowman-Birk protease inhibitor. Carcinogenesis. 12:1991;2147-2150.
325. Wan, X. S., Koch, C. J., Lord, E. M., Manzone, H., Billings, P. C., Donahue, J. J., Odell, C. S., Miller J. and Kennedy, A. R. (1995) Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor. J. Immunol. Methods 180: 117-130.
326. Ware J.H., Wan X.S., Rubin H., Schechter N.M., Kennedy A.R. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch. Biochem. Biophys. 344:1997;133-138.
327. Wargovich M.J., Bauer A.R., Hu P.J., Sumiyoshi H. Dietary factors and colorectal cancer. Gastroenterol. Clin. North Am. 7:1988;727-745.
328. Watanabe S., Shiratori K., Takeuchi T., Chey W.Y. Intrajejunal administration of a synthetic trypsin inhibitor (camostate) stimulates the release of endogenous secretin but not cholecystokinin in humans. Gastroenterology. 90:1986;1685.
329. Weed H., McGandy R.B., Kennedy A.R. Protection against dimethylhydrazine induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis. 6:1985;1239-1241.
330. Weeke B., Jarnum S. Serum concentrations of 19 serum proteins in Crohn's disease and ulcerative colitis. Gut. 12:1971;297-302.
331. Weinstein I.B. Current concepts on mechanisms of chemical carcinogenesis. Bull. NY Acad. Med. 54:1978;366-383.
332. Werner M.H., Wemmer D.E. Three-dimensional structure of soybean trypsin/chymotrypsin Bowman-Birk Inhibitor in solution. Biochemistry. 31:1992;999-1010.
333. Winn D.M., Ziegler R.G., Pickle L.W., Gridley G., Blot W.J., Hoover R.N. Diet in the etiology of oral and pharyngeal cancer among women from the southern United States. Cancer Res. 44:1984;1216-1222.
334. Wintersberger U. The selective advantage of cancer cells. a consequence of genome mobilization in the course of the induction of DNA repair processes? (model studies on yeast) Adv. Enzyme Regul. 22:1984;311-323.
335. Witkin E.M. Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli. Bacteriol. Rev. 40:1976;869-907.
336. Witschi H., Kennedy A.R. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Carcinogenesis. 10:1989;2275-2277.
337. Witte, J. (1979) Endotoxinamie und hyperdynamer septischer Schock: Pathobiochemie ausgewahlter Gerinnungs- und anderer Plasma-Protein-parameter. Habilitation script, Medical Faculty of the University of Munich.
338. Witz G., Goldstein B.D., Amoruso M., Stone D.S., Troll W. Retinoid inhibition of superoxide anion radical production by human polymorphonuclear leukocytes stimulated with tumor promoters. Biochem. Biophys. Res. Commun. 97:1980;883-888.
339. Wolf, W. J. and Cowan, J. C. (1975) Soybeans as a Food Source. CRC Press, Inc., Cleveland.
340. Wynder E.L. An epidemiological evaluation of the causes of cancer of the pancreas. Cancer Res. 35:1975;2228-2233.
341. Yamamoto R.S., Umezawa H., Takeuchi T., Matsushima T., Hara K., Sugimura T. Effect of leupeptin on colon carcinogenesis in rats with azoxymethane. Proc. Am. Assoc. Cancer Res. 15:1974;38.
342. Yamamura M., Nakamura N., Fukui Y., Takamura C., Yamamoto M., Minato Y., Tamura Y., Jujii S. Inhibition of 7,12 DMBA-induced mammary tumorigenesis by a synthetic protease inhibitor, N,N-dimethylamino (p-p′-guanidino-benzoyloxy) benzilcarbonyloxyglycolate. Gann. 69:1978;749-752.
343. Yamauchi Y., Kobayashi T., Watanabe A. Anticarcinogenic effects of a serine protease inhibitor (Foy-305) through the suppression of neutral serine protease activity during chemical hepatocarcinogenesis in rats. Hiroshima J. Med. Sci. 36:1987;81-87.
344. Yanatori Y., Fujita T. Hypertrophy and hyperplasia in the endocrine and exocrine pancreas of rats fed soybean trypsin inhibitor or repeatedly injected with pancreozymin. Arch. Histol. Japan. 39:1976;67-78.
345. Yavelow J., Gidlund M., Troll W. Protease inhibitors from processed legumes effectively inhibit superoxide generation in response to TPA. Carcinogenesis. 1:1982;135-138.
346. Yavelow J., Finlay T.H., Kennedy A.R., Troll W. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res. 43:1983;2454-2459.
347. Yavelow J., Collins M., Birk Y., Troll W., Kennedy A.R. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc. Natl. Acad. Sci. USA. 82:1985;5395-5399.
348. Yavelow J., Caggaga M., Beck K.A. Proteases occurring in the cell membrane. a possible receptor for the Bowman-Birk type of protease inhibitors Cancer Res. 47:1987;1598-1601.
349. Yavelow, J., Schepis, L. T., Nickels, J. and Ritchie, G. (1993) Cell membrane enzymes containing chymotrypsin-like activity. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 217-226, Troll, W. and Kennedy, A. R. (eds.) Plenum Publishing Corp., New York and London.
350. Yen J.T., Jensen A.H., Simon J. Effect of dietary raw soybean and soybean trypsin inhibitor on trypsin and chymotrypsin activities in the pancreas and in small intestinal juice of growing swine. J. Nutr. 107:1977;156-165.
351. Young V.R., Wayler A., Garza C., Steinke F.H., Murray E., Rand W.M., Scrimshaw N.S. A long-term metabolic balance study in young men to assess the nutritional quality of an isolated soy protein and beef proteins. Am. J. Clin. Nutr. 39:1984;8-15.
352. Yuspa S.H., Koehler B.A., Kulesz-Martin M., Hennings H. Clonal growth of mouse epidermal cells in medium with reduced calcium concentration. J Invest. Dermatol. 76:1981;144-146.
353. 2+-activated neutral protease in rat liver following carbon tetrachloride administration. Biochem. Biophys. Res. Commun. 197:1993;585-590.